Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
health surveillance data
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
Januarty 2002 to Febbruary 2002
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: A small study carried out using the exposed population, a deficiency was that the study only considered workers in the UK factories of the study sponsors
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Study type:
medical screening
Endpoint addressed:
skin sensitisation
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Clinical examination of workforce by expert dermatologist
GLP compliance:
no

Test material

Constituent 1
Reference substance name:
oxo[(oxoalumanyl)oxy]alumane; silanedione
EC Number:
604-314-4
Cas Number:
142844-00-6
Molecular formula:
amorphous glass Si(n)O(3n+1) polymeric anions bonded to Zr and Al(3+)
IUPAC Name:
oxo[(oxoalumanyl)oxy]alumane; silanedione
Details on test material:
- Name of test material (as cited in study report): Ceramic fibre, Zircon

Method

Type of population:
occupational
Ethical approval:
confirmed, but no further information available
Details on study design:
Questionnaire and full clinical examination

Results and discussion

Results:
The results of this study performed in 2 RCF manufacturing facilities in UK found no evidence of skin disease leading to chronic change or any skin problem requiring any long term treatment, causing long term changes to the skin, causing time off work or fundamentally altering an employees' life style. The spectrum of skin disease found in these populations followed a normal distribution and had no association to exposure to RCF.

Any other information on results incl. tables

Table 1 Profile of employees with and without skin disease

 

WITH Complaint of skin Disease

WITHOUT Complaint of skin Disease

Average age

45.75

42.73

Duration of Employment

13.2 years

11.4 years

Table 2 –Profile of itch when first started

SITE

Duration

Findings on examination

Arms/Face

Few days

Nil

Arms

Few days

Nil

Neck/Arms/Face

2-3 weeks

Nil

Face/Arms

2-3 Weeks

Nil

Forearms

2 months

Psoriasis

Neck/Arms/Legs

2 weeks

Acne

Applicant's summary and conclusion

Executive summary:

This study was undertaken following a publication of positve results on skin effects from Poland the Polish dermatologist involved in the earlier study also took part in this study and confirmed the absence of any effects on these workers. The origin of the skin lessions seen in Poland remains unknown.